新疆驴脑组织尼帕病毒N基因片段的检测

目的检测新疆伊犁草原地区放养新疆驴的脑组织样本中尼帕病毒(Nipah Virus,NiV)核蛋白(N)基因片段,调查该地区放养新疆驴NiV感染流行状况。方法采用一步法实时荧光定量逆转录聚合酶链反应(one-step Real-Time FQ RT-PCR)对采自新疆伊犁地区草原放养且未接种NiV疫苗的65例新疆驴脑组织进行NiVN基因片段检测。结果新疆驴脑组织标本中未检出NiV N基因片段。结论目前尚无证据表明我国新疆伊犁地区新疆驴中存在NiV感染,提示该地区短时间内爆发该病毒感染可能性较小。     

新疆伊犁地区驴脑组织亨德拉病毒感染情况调查

目的调查新疆伊犁地区草原放养驴群中亨德拉病毒(Hendra virus,HeV)中枢感染的流行情况。方法采用一步法实时荧光定量RT-PCR检测病毒核酸片段的方法对采自新疆伊犁地区草原放养、未接种HeV疫苗的65例驴脑组织进行HeV核蛋白(N)基因片段检测。结果65例驴脑组织成功进行一步法实时荧光定量RT-PCR检测,未检出阳性样本。结论目前尚未发现我国新疆伊犁地区放养驴中存在HeV中枢神经感染的证据,提示该地区出现HeV感染流行的可能性不大。     

新疆伊犁地区马匹亨德拉病毒脑内感染情况调查

目的检测新疆伊犁地区天然牧场放养马群脑组织中亨德拉病毒（Hendra Virus,HeV）的核酸片段,调查该地区马群中枢神经系统HeV感染流行状况。方法针对HeV高度保守区核蛋白（N）基因设计特异性引物和探针,采用一步法实时荧光定量RT-PCR检测中枢神经系统感染样本中低浓度HeV RNA的方法,检测新疆伊犁草原地区天然放养且未接种HeV疫苗的183例马匹脑组织。结果最低特异性检出浓度可低至2.6×102copies/μL,与其他单股负链RNA病毒如同属的尼帕病毒（NiV）无交叉反应,对183例马脑组织进行一步法实时荧光定量RT-PCR检测,未检出阳性样本。结论初步流行病学研究尚未发现我国新疆伊犁地区天然牧场放养马匹中存在HeV感染的证据,提示该地区短时间内爆发亨德拉病毒感染的可能性小。     

新疆部分地区动物Nipah病毒和Hendra病毒感染的调查

拟建立一步法实时RT-PCR检测Nipah病毒(Nipah virus,NiV)、Hendra病毒(Hendra virus,HeV)的方法,对采集自中国新疆部分地区动物外周血样本进行NiV和HeV检测,以获得我国新疆地区的NiV和HeV的病毒流行病学资料.采用NiV和HeV一步法实时RT-PCR检测方法,对2007年9-12月采集的新疆伊犁河谷地区以及巴音布鲁克草原放养的500匹马、100匹驴和160只犬外周血单个核细胞RNA进行NiV和HeV N基因片段检测.结果:对采集的动物血样本进行NiV和HeV核酸检测,成功进行了一步法实时RT-PCR反应,没有发现阳性样本.初步流行病学研究提示我国新疆部分地区天然牧场放养的动物中可能不存在NiV和HeV感染,该地区出现NiV和HeV爆发的可能性较小.     

新疆伊犁地区马脑组织西尼罗病毒感染的调查

目的了解新疆伊犁地区草原放养马群中西尼罗病毒(W estN ile virus,WNV)中枢感染的流行状况。方法采用一步法实时荧光定量逆转录聚合酶链反应(Real Tim e RT-PCR)对采自新疆伊犁地区草原放养、未接种WNV疫苗的189例马脑组织进行WNV包膜蛋白(E)基因片段检测。结果被检马脑组织标本中未发现WNV E基因片段。结论目前尚没有证据表明我国新疆伊犁地区的放养马中存在WNV脑炎的感染,提示该地区出现WNV脑炎流行的可能性小。     

表达尼帕病毒G囊膜糖蛋白重组牛痘病毒的研究

采用牛痘病毒WR株,构建了表达哺乳动物密码子优化的NiV G蛋白基因的重组病毒rWR-NiV-G。Westernblot证实大小为66kDa的重组G蛋白在rWR-NiV-G感染的Hela细胞中获得表达;采用兔抗NiV高免血清间接免疫荧光检测重组痘病毒表达G蛋白显示出良好的特异免疫反应原性。rWR-NiV-G感染NiV敏感的BHK细胞系,并与NiV融合蛋白F共同表达,可形成强烈细胞融合现象。rWR-NiV-G感染免疫BALB/c小鼠,可诱导显著的NiV G蛋白特异体液免疫反应。以原核表达NiV G蛋白片段为包被抗原,间接ELISA检测rWR-NiV-G感染免疫小鼠血清中的G蛋白特异抗体,具有良好的敏感性和特异性。同时,rWR-NiV-G感染免疫小鼠血清中的G蛋白特异抗体可有效中和NiV囊膜蛋白F和G介导的伪型VSV重组病毒侵入NiV易感宿主细胞的感染性。结果表明,重组牛痘病毒表达的NiV G蛋白有良好的免疫原性和生物学活性功能,为进一步深入研究NiV G蛋白生物学功能、免疫原性及重组活载体疫苗研究奠定了重要基础。     

铃木氏果蝇不同地理种群中Wolbachia的检测和系统发育分析

铃木氏果蝇Drosophila suzukii是原产于东南亚地区的重要果树害虫, 近年来传入北美和欧洲等地区造成严重的危害。本研究利用Wolbachia的16S rDNA和wsp基因特异引物（分别为16S-F/16S-R和81F/691R）对铃木氏果蝇7个地理种群（中国的5个种群、 韩国的1个种群和美国的1个种群）的Wolbachia进行了PCR检测并对检测结果进行了比较; 对感染个体体内Wolbachia的16S rDNA基因片段进行测序, 确定了我国铃木氏果蝇体内Wolbachia的分类地位。基于Wolbachia的16S rDNA基因特异引物检测结果发现, 我国5个铃木氏果蝇种群广泛感染Wolbachia（感染率36.7%~80.0%）, 而韩国和美国2个种群均未检测到该菌的感染。而利用wsp基因特异引物无法检测到该菌。基于Wolbachia的16S rDNA基因构建系统发育树表明, 我国铃木氏果蝇种群感染的Wolbachia全部属于A组。这些结果为研究Wolbachia感染对铃木氏果蝇生物学及生态学的影响奠定了基础。     

尼帕病毒Taqman qRT-PCR检测方法的建立

尼帕病毒(NiV)是一种高致病性人畜共患病原体,可引起人类致死性脑炎和严重的呼吸系统疾病,目前尚无有效的抗NiV药物和疫苗,建立NiV检测方法十分必要。建立针对尼帕病毒N基因的Taqman qRT-PCR检测方法,应用于样本尼帕病毒检测及定量。针对尼帕病毒N基因保守区域设计引物和探针,建立Taqman qRT-PCR检测方法,评价该检测方法灵敏度、特异性和可重复性,并应用此方法进行样本检测。本研究建立的Taqman qRT-PCR检测方法可以特异性的检测尼帕病毒,检测灵敏度为10~2拷贝/μL,标准曲线线性范围为1.0×10~9～1.0×10~2拷贝/μL,可重复性较好,能够有效检出尼帕病毒马来西亚病毒株和孟加拉病毒株,可用于样本尼帕病毒的检测及定量。     

尼帕病毒F糖蛋白在重组牛痘病毒中的表达及鉴定

尼帕病毒(NiV)F蛋白在病毒侵入细胞和诱导中和抗体等方面具有重要作用。通过over-lapping PCR合成密码子优化的F蛋白基因构建了表达NiV F蛋白的重组牛痘病毒(WR株)rWR-NiV-F。利用兔抗NiV血清为检测抗体,通过间接免疫荧光(IFA)检测到了F蛋白在重组病毒感染细胞中的表达。SDS-PAGE和Western blot检测证明重组蛋白F0被裂解为F1和F2。以rWR-NiV-F感染瞬时转染共表达NiV受体结合囊膜糖蛋白G的BHK细胞,可诱导细胞膜融合及合包体形成,证明该重组病毒表达F蛋白保持良好的抗原性及生物学活性,为NiV诊断及重组活载体疫苗研究奠定了重要基础。     

鼻咽癌中Epstein—Barr病毒基因结构特点

鼻咽癌中感染的ＥＢＶ以潜伏态存在,只有少数基因得到表达。我们从分子生物学水平研究其潜伏机制。已知ＲＺＬＦ１基因和ＢａｍＨＩＥＺ片段内部分基因对ＥＢＶ的复制激活起关键作用。我们用体外基因扩增（ＰＣＲ）法扩增ＢＺＬＦ１基因外显子－１序列,并用序列分析法研究了该基因结构特点。此外,检测了ＢａｍＨＩＥＺ片段内的基因缺失,结果发现２１例鼻咽癌（ＮＰＣ）组织中,１１例有ＢａｍＨＩＥＺ片段内缺失,长达２．９９ｋ     

Early Activation of Primary Brain Microvascular Endothelial Cells by Nipah Virus Glycoprotein-Containing Particles

Nipah virus (NiV) is a highly pathogenic paramyxovirus that causes pronounced infection of brain endothelia and central nervous system (CNS) inflammation. Using primary porcine brain microvascular endothelial cells, we showed that upregulation of E-selectin precedes cytokine induction and is induced not only by infectious NiV but also by NiV-glycoprotein-containing virus-like particles. This demonstrates that very early events in NiV brain endothelial infection do not depend on NiV replication but can be triggered by the NiV glycoproteins alone.     

Recombinant Measles Virus Vaccine Expressing the Nipah Virus Glycoprotein Protects against Lethal Nipah Virus Challenge

Nipah virus (NiV) is a member of the genus Henipavirus, which emerged in Malaysia in 1998. In pigs, infection resulted in a predominantly non-lethal respiratory disease; however, infection in humans resulted in over 100 deaths. Nipah virus has continued to re-emerge in Bangladesh and India, and person-to-person transmission appeared in the outbreak. Although a number of NiV vaccine studies have been reported, there are currently no vaccines or treatments licensed for human use. In this study, we have developed a recombinant measles virus (rMV) vaccine expressing NiV envelope glycoproteins (rMV-HL-G and rMV-Ed-G). Vaccinated hamsters were completely protected against NiV challenge, while the mortality of unvaccinated control hamsters was 90%. We trialed our vaccine in a non-human primate model, African green monkeys. Upon intraperitoneal infection with NiV, monkeys showed several clinical signs of disease including severe depression, reduced ability to move and decreased food ingestion and died at 7 days post infection (dpi). Intranasal and oral inoculation induced similar clinical illness in monkeys, evident around 9 dpi, and resulted in a moribund stage around 14 dpi. Two monkeys immunized subcutaneously with rMV-Ed-G showed no clinical illness prior to euthanasia after challenge with NiV. Viral RNA was not detected in any organ samples collected from vaccinated monkeys, and no pathological changes were found upon histopathological examination. From our findings, we propose that rMV-NiV-G is an appropriate NiV vaccine candidate for use in humans.     

The Distribution of Henipaviruses in Southeast Asia and Australasia: Is Wallace’s Line a Barrier to Nipah Virus?

Nipah virus (NiV) (Genus Henipavirus) is a recently emerged zoonotic virus that causes severe disease in humans and has been found in bats of the genus Pteropus. Whilst NiV has not been detected in Australia, evidence for NiV-infection has been found in pteropid bats in some of Australia’s closest neighbours. The aim of this study was to determine the occurrence of henipaviruses in fruit bat (Family Pteropodidae) populations to the north of Australia. In particular we tested the hypothesis that Nipah virus is restricted to west of Wallace’s Line. Fruit bats from Australia, Papua New Guinea, East Timor and Indonesia were tested for the presence of antibodies to Hendra virus (HeV) and Nipah virus, and tested for the presence of HeV, NiV or henipavirus RNA by PCR. Evidence was found for the presence of Nipah virus in both Pteropus vampyrus and Rousettus amplexicaudatus populations from East Timor. Serology and PCR also suggested the presence of a henipavirus that was neither HeV nor NiV in Pteropus alecto and Acerodon celebensis. The results demonstrate the presence of NiV in the fruit bat populations on the eastern side of Wallace’s Line and within 500 km of Australia. They indicate the presence of non-NiV, non-HeV henipaviruses in fruit bat populations of Sulawesi and Sumba and possibly in Papua New Guinea. It appears that NiV is present where P. vampyrus occurs, such as in the fruit bat populations of Timor, but where this bat species is absent other henipaviruses may be present, as on Sulawesi and Sumba. Evidence was obtained for the presence henipaviruses in the non-Pteropid species R. amplexicaudatus and in A. celebensis. The findings of this work fill some gaps in knowledge in geographical and species distribution of henipaviruses in Australasia which will contribute to planning of risk management and surveillance activities.